Jesper Van Breeschoten

Amsterdam, NH 1081HZ, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Prolonged antibiotic treatment durations for community-onset infections in Dutch hospitals.

Prolonged antibiotic treatment durations for community-onset infections in Dutch hospitals.

Journal: Antimicrobial stewardship & healthcare epidemiology : ASHE

Published: November 20, 2025

Improving survival in advanced melanoma patients: a trend analysis from 2013 to 2021.

Improving survival in advanced melanoma patients: a trend analysis from 2013 to 2021.

Journal: EClinicalMedicine

Published: September 11, 2023

Real-world Outcomes of Ipilimumab Plus Nivolumab Combination Therapy in a Nation-wide Cohort of Advanced Melanoma Patients in the Netherlands.

Real-world Outcomes of Ipilimumab Plus Nivolumab Combination Therapy in a Nation-wide Cohort of Advanced Melanoma Patients in the Netherlands.

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)

Published: December 09, 2022

Population mortality in advanced melanoma patients with and without response and progression; data from the Dutch Melanoma Treatment Registry.

Population mortality in advanced melanoma patients with and without response and progression; data from the Dutch Melanoma Treatment Registry.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 28, 2022

End-of-Life Use of Systemic Therapy in Patients With Advanced Melanoma: A Nationwide Cohort Study.

End-of-Life Use of Systemic Therapy in Patients With Advanced Melanoma: A Nationwide Cohort Study.

Journal: JCO oncology practice

Published: August 09, 2022

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis.

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis.

Journal: British journal of cancer

Published: March 08, 2022

Response to: Effect of dose reductions on clinical outcomes, or of outcomes on dose reductions?

Response to: Effect of dose reductions on clinical outcomes, or of outcomes on dose reductions?

Journal: Breast (Edinburgh, Scotland)

Published: February 22, 2022

Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort study.

Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 15, 2021

Palbociclib dose reductions and the effect on clinical outcomes in patients with advanced breast cancer.

Palbociclib dose reductions and the effect on clinical outcomes in patients with advanced breast cancer.

Journal: Breast (Edinburgh, Scotland)

Published: November 01, 2021

Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis.

Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis.

Journal: Journal of medical Internet research

Published: September 29, 2021

Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer.

Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer.

Journal: JAMA network open

Published: September 10, 2021

Hospital Variation in Cancer Treatments and Survival OutComes of Advanced Melanoma Patients: Nationwide Quality Assurance in The Netherlands.

Hospital Variation in Cancer Treatments and Survival OutComes of Advanced Melanoma Patients: Nationwide Quality Assurance in The Netherlands.

Journal: Cancers

Published: August 03, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026